New study conducted through the drug Liraglutide would enhance obese people to loss weight. The drug approved by US regulators will help people carrying excessive body weight to shed at least 18 pounds of the weight.
The study was conducted last year before the injectable drug was approved by the US regulator as effective on the problem of diabetes and excessive weight loss.
However, the research was conducted in a randomized 191 sites in Africa, Europe, Asia, North and South America. The findings after the conduct of the study show the drug will go a long way in solving the problem of obesity.
Patients in the study were claimed to be 18 years old and each of them carrying a body mass index above 30. Close to 4000 people went under the study and about two third received the drug plus training in improving lifestyle habits.
The drug carries such side effect as increase in breast cancer and gastrolinal distress. Researchers have concluded that more is needed to ally the abnormality of breast cancer and tumour growth.
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate